Chronic Bronchitis News and Research

RSS
GSK reports positive results from Incruse Ellipta and Advair Diskus combination therapy in COPD patients

GSK reports positive results from Incruse Ellipta and Advair Diskus combination therapy in COPD patients

Study shows commonly used statin drug does not reduce acute COPD exacerbations

Study shows commonly used statin drug does not reduce acute COPD exacerbations

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

Researchers launch detailed atlas with environment and health maps

Researchers launch detailed atlas with environment and health maps

COPD sufferers can reduce risk of being hospitalized by walking 3 kilometers a day

COPD sufferers can reduce risk of being hospitalized by walking 3 kilometers a day

Ario Pharma begins XEN-0501 Phase IIa study for treatment persistent cough in COPD patients

Ario Pharma begins XEN-0501 Phase IIa study for treatment persistent cough in COPD patients

Smoking and cancer: an interview with Dr. Lewis Foxhall, VP of Health Policy, University of Texas MD Anderson Cancer Center

Smoking and cancer: an interview with Dr. Lewis Foxhall, VP of Health Policy, University of Texas MD Anderson Cancer Center

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

Study finds that people with COPD twice likely to develop mild cognitive impairment, memory loss

Study finds that people with COPD twice likely to develop mild cognitive impairment, memory loss

BAL findings boost non-smoking COPD distinction

BAL findings boost non-smoking COPD distinction

Chronic bronchitis could indicate COPD subtype

Chronic bronchitis could indicate COPD subtype

Once-daily prescription medicine for COPD now available throughout the U.S.

Once-daily prescription medicine for COPD now available throughout the U.S.

Scientists develop new drug to treat obstructive airway diseases

Scientists develop new drug to treat obstructive airway diseases

Leukemia drug reverses symptoms of colitis in lab tests

Leukemia drug reverses symptoms of colitis in lab tests

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

Chronic bronchitis linked to poor asthma outcomes

Chronic bronchitis linked to poor asthma outcomes

UNC receives grants from FDA and NIH to establish Tobacco Centers of Regulatory Science

UNC receives grants from FDA and NIH to establish Tobacco Centers of Regulatory Science

Inhaled corticosteroid increases risk for pneumonia reoccurrence

Inhaled corticosteroid increases risk for pneumonia reoccurrence

Patients with COPD show improvements in lung function with olodaterol

Patients with COPD show improvements in lung function with olodaterol

Drug can be delivered safely to people with COPD in both "mist" and "dry powder" inhalers, say experts

Drug can be delivered safely to people with COPD in both "mist" and "dry powder" inhalers, say experts